购物车
- 全部删除
您的购物车当前为空
Anti-TNF beta Antibody (4T830)
还可以
产品编号 TMAC-02426
Anti-TNF beta Antibody (4T830) 是一种 Mouse 抗体，靶向 TNF beta。Anti-TNF beta Antibody (4T830) 可用于 WB。
Anti-TNF beta Antibody (4T830)
Anti-TNF beta Antibody (4T830)
还可以产品编号 TMAC-02426
Anti-TNF beta Antibody (4T830) 是一种 Mouse 抗体，靶向 TNF beta。Anti-TNF beta Antibody (4T830) 可用于 WB。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μL | ¥ 1,980 | 5日内发货 | |
| 100 μL | ¥ 2,995 | 5日内发货 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
化学信息
| 产品描述 | Anti-TNF beta Antibody (4T830) is a Mouse antibody targeting TNF beta. Anti-TNF beta Antibody (4T830) can be used in WB. |
| 交叉反应 | Human,Rat |
| 验证活性 | 1. Western blot analysis on recombinant LT-alpha (TNF-β) using anti-LT-alpha monoclonal antibody. |
| 应用 | |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | Hybridoma Monoclonal Antibody |
| 纯化方式 | ProA affinity purified |
| 性状 | Liquid |
| 缓冲液 | 1*TBS (pH7.4), 0.5%BSA, 25%Glycerol. Preservative: 0.05% Sodium Azide. |
| 研究背景 | Lymphotoxin-alpha (LTA), a member of the tumor necrosis factor (TNF) family of cytokines, was initially isolated on the basis of an tumor activity. LTA plays a key role in communication between lymphocytes and stromal cells, thereby eliciting cytotoxic effects on cancer cells. It induces the expression of vascular cell-adhesion molecule 1 (VCAM1) on vascular endothelial cells and recruits natural killer (NK) cells to parenchymal organs and tumor lesions. |
| 偶联 | Unconjugated |
| 免疫原 | Peptide |
| Uniprot ID |
| 分子量 | Theoretical: 18 kDa. |
存储&运输
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
SCI 文献
关键词
评论列表
预览
Related Tags: buy Anti-TNF beta Antibody (4T830) | purchase Anti-TNF beta Antibody (4T830) | Anti-TNF beta Antibody (4T830) cost | order Anti-TNF beta Antibody (4T830) | Anti-TNF beta Antibody (4T830) molecular weight
嗨！有任何问题？点我咨询
评论内容